WEDNESDAY, Dec. 11, 2024 -- For patients with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL), obecabtagene autoleucel (obe-cel), an...

WEDNESDAY, Dec. 11, 2024 -- For patients with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL), obecabtagene autoleucel (obe-cel), an...

THURSDAY, Dec. 12, 2024 -- For patients with newly diagnosed, standard-risk B-cell acute lymphoblastic leukemia (ALL) with an average or high risk for...

WEDNESDAY, Dec. 11, 2024 -- In most countries, prostate cancer incidence and mortality rates decreased or were stable in the most recent five-year...

WEDNESDAY, Dec. 11, 2024 -- In most countries, prostate cancer incidence and mortality rates decreased or were stable in the most recent five-year...

WEDNESDAY, Dec. 11, 2024 -- For patients undergoing liver resection, hypovolemic phlebotomy reduces perioperative red blood cell transfusions compared...

WEDNESDAY, Dec. 11, 2024 -- For patients undergoing liver resection, hypovolemic phlebotomy reduces perioperative red blood cell transfusions compared...

WEDNESDAY, Dec. 11, 2024 -- Elevated blood pressure variability (BPV), especially in older Black adults, is associated with lower cognitive scores,...

WEDNESDAY, Dec. 11, 2024 -- Elevated blood pressure variability (BPV), especially in older Black adults, is associated with lower cognitive scores,...

A preclinical study led by a faculty member at Roswell Park Comprehensive Cancer Center shows that gilteritinib, a targeted cancer treatment, can...